BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30268445)

  • 1. Novel gene mutations in well-differentiated fetal adenocarcinoma of the lung in the next generation sequencing era.
    Fu Y; Wu Q; Su F; Tang Y; Lin Y; Wang W; Jiang L
    Lung Cancer; 2018 Oct; 124():1-5. PubMed ID: 30268445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules.
    Nakatani Y; Masudo K; Miyagi Y; Inayama Y; Kawano N; Tanaka Y; Kato K; Ito T; Kitamura H; Nagashima Y; Yamanaka S; Nakamura N; Sano J; Ogawa N; Ishiwa N; Notohara K; Resl M; Mark EJ
    Mod Pathol; 2002 Jun; 15(6):617-24. PubMed ID: 12065775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morules and morule-like features associated with carcinomas in various organs: report with immunohistochemical and molecular studies.
    Makishi S; Kinjo T; Sawada S; Chinen K; Hirayasu T; Hamada T; Saito K; Iwamasa T
    J Clin Pathol; 2006 Jan; 59(1):95-100. PubMed ID: 16394288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic features and genomic analysis of pulmonary blastomatoid carcinosarcoma.
    Zhao J; Xiang C; Zhao R; Guo P; Zheng J; Han-Zhang H; Yu K; Zhang J; Han Y
    BMC Cancer; 2020 Mar; 20(1):248. PubMed ID: 32209061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An oncogenic CTNNB1 mutation is predictive of post-operative recurrence-free survival in an EGFR-mutant lung adenocarcinoma.
    Kim Y; Ahn B; Yoon S; Lee G; Kim D; Chun SM; Kim HR; Jang SJ; Hwang HS
    PLoS One; 2023; 18(6):e0287256. PubMed ID: 37347751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant nuclear/cytoplasmic localization and gene mutation of beta-catenin in classic pulmonary blastoma: beta-catenin immunostaining is useful for distinguishing between classic pulmonary blastoma and a blastomatoid variant of carcinosarcoma.
    Nakatani Y; Miyagi Y; Takemura T; Oka T; Yokoi T; Takagi M; Yokoyama S; Kashima K; Hara K; Yamada T; Nozawa A; Inayama Y; Sakamoto K; Ogawa N; Kitamura H; Resl M; Cho SH; Koss MN; Mark EJ
    Am J Surg Pathol; 2004 Jul; 28(7):921-7. PubMed ID: 15223963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-catenin mutations in pulmonary blastomas: association with morule formation.
    Sekine S; Shibata T; Matsuno Y; Maeshima A; Ishii G; Sakamoto M; Hirohashi S
    J Pathol; 2003 Jun; 200(2):214-21. PubMed ID: 12754743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphologic, Immunohistochemical, and Genetic Differences Between High-grade and Low-grade Fetal Adenocarcinomas of the Lung.
    Li Y; Xi SY; Yong JJ; Wu XY; Yang XH; Wang F
    Am J Surg Pathol; 2021 Nov; 45(11):1464-1475. PubMed ID: 34138800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic angiomyolipoma: mutation analysis and immunohistochemical pitfalls in diagnosis.
    Yan Z; Grenert JP; Joseph NM; Ren C; Chen X; Shafizadeh N; Kakar S
    Histopathology; 2018 Jul; 73(1):101-108. PubMed ID: 29512829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration in the Wnt/β-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type.
    Hidaka Y; Mitomi H; Saito T; Takahashi M; Lee SY; Matsumoto K; Yao T; Watanabe S
    Hum Pathol; 2013 Nov; 44(11):2438-48. PubMed ID: 24011952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive Patterns of CTNNB1 (β-Catenin) Alterations in Salivary Gland Basal Cell Adenoma and Basal Cell Adenocarcinoma.
    Jo VY; Sholl LM; Krane JF
    Am J Surg Pathol; 2016 Aug; 40(8):1143-50. PubMed ID: 27259009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. V600E BRAF versus Non-V600E BRAF Mutated Lung Adenocarcinomas: Cytomorphology, Histology, Coexistence of Other Driver Mutations and Patient Characteristics.
    Salimian KJ; Fazeli R; Zheng G; Ettinger D; Maleki Z
    Acta Cytol; 2018; 62(2):79-84. PubMed ID: 29320776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline and Somatic DICER1 Mutations in a Well-Differentiated Fetal Adenocarcinoma of the Lung.
    de Kock L; Bah I; Wu Y; Xie M; Priest JR; Foulkes WD
    J Thorac Oncol; 2016 Mar; 11(3):e31-3. PubMed ID: 26886166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the Lung.
    Righi L; Vatrano S; Di Nicolantonio F; Massa F; Rossi G; Cavazza A; Volante M; Votta A; Izzo S; Lo Iacono M; Ardissone F; Di Maio M; Novello S; Scagliotti GV; Papotti M
    J Thorac Oncol; 2016 Apr; 11(4):504-15. PubMed ID: 26774193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Lung Cribriform Adenocarcinoma With Squamoid Morules Harboring Somatic
    Wu H; Ye Q; Razzano D; Tugal O; Rosenblum J; Weigel T; Zhong M
    Pediatr Dev Pathol; 2020; 23(6):472-475. PubMed ID: 32924814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-grade fetal adenocarcinoma of the lung is a tumour with a fetal phenotype that shows diverse differentiation, including high-grade neuroendocrine carcinoma: a clinicopathological, immunohistochemical and mutational study of 20 cases.
    Suzuki M; Yazawa T; Ota S; Morimoto J; Yoshino I; Yamanaka S; Inayama Y; Kawabata Y; Shimizu Y; Komatsu M; Notohara K; Koda K; Nakatani Y
    Histopathology; 2015 Dec; 67(6):806-16. PubMed ID: 25851923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival prediction for patients with lung adenocarcinoma: A prognostic risk model based on gene mutations.
    Geng H; Li S; Guo Y; Yan F; Han Y; Xu M; Cui Y
    Cancer Biomark; 2020; 27(4):525-532. PubMed ID: 32083571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway.
    Zhan P; Zhang B; Xi GM; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu QQ; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Qian LP; Lv TF; Song Y
    Mol Cancer; 2017 Jun; 16(1):108. PubMed ID: 28646916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Well-differentiated fetal adenocarcinoma of the lung: cytomorphologic features on fine-needle aspiration with emphasis on use of beta-catenin as a useful diagnostic marker.
    Proctor L; Folpe AL; Esper A; Wolfenden LL; Force S; Logani S
    Diagn Cytopathol; 2007 Jan; 35(1):39-42. PubMed ID: 17173289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-small cell lung carcinomas with CTNNB1 (beta-catenin) mutations: A clinicopathological study of 26 cases.
    Thomas de Montpréville V; Lacroix L; Rouleau E; Mamodaly M; Leclerc J; Tutuianu L; Planchard D; Boulate D; Mercier O; Besse B; Fadel É; Ghigna MR
    Ann Diagn Pathol; 2020 Jun; 46():151522. PubMed ID: 32442860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.